CVS HEALTH Corp

2. Key Holdings

The portfolio is overwhelmingly dominated by a single position: the SPDR S&P 500 ETF Trust (SPY). This holding comprises $102.52 million, accounting for 99.91% of the total portfolio. With 154,000 shares, CVS Health Corp is effectively using this vehicle as a core liquidity or market proxy. The second holding, Health Catalyst Inc, represents a negligible 0.09% of the portfolio ($91,98K). While Health Catalyst operates in the healthcare data analytics sector, its minuscule allocation renders it immaterial to the overall portfolio performance, suggesting it may be a legacy position or a strategic stake kept for non-financial reasons, such as corporate partnerships.

3. Sector Allocation

Sector allocation in this filing is straightforward and heavily skewed toward passive market exposure. Approximately 99.91% of the portfolio is allocated to a broad-market ETF (SPY), which provides exposure to the large-cap U.S. equity market across all sectors. The remaining 0.09% is classified as "Unknown," corresponding to the Health Catalyst holding. Notably, there is no direct allocation to specific sectors such as Healthcare, Finance, or Technology, despite CVS Health Corp itself being a major healthcare entity. This indicates that the investment portfolio is managed separately from the company’s operational subsidiaries and is likely utilized for capital preservation or general corporate liquidity rather than sector-specific strategic investing.